Our Insights

Insights

Discover the latest insights from Capstone analysts offering perspectives on policy and regulatory issues that we believe investors and businesses underappreciate. Our thought-provoking analyses are designed to empower leaders to navigate complex challenges and drive successful outcomes.

Clinical Trials Face an Enrollment Problem; Washington Is Betting on AI

The second Trump administration is deeply supporting technology in healthcare, including in asking questions about how artificial intelligence (AI) could revolutionize trials. In clinical trials, the tech-forward shift began during the COVID-19 pandemic, when researchers had to either adapt to the new remote reality or end trials.

FEATURED CHART

Charts of the month

 Contact Us